Free radicals and antioxidantsThe oxidation hypothesis of atherosclerosis
References (22)
- et al.
Role of oxidatively modified LDL in atherosclerosis
Free Radic Biol Med
(1990) - et al.
Evidence of a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages
J Lipid Res
(1991) - et al.
The role of lipid peroxidation and antioxidants in oxidative modification of LDL
Free Radic Biol Med
(1992) - et al.
Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL)
J Lipid Res
(1994) - et al.
Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity
N Engl J Med
(1989) - et al.
Lipoproteins and atherogenesis: current concepts
JAMA
(1990) The pathogenesis of atherosclerosis: a perspective for the 1990s
Nature
(1993)Role of oxidised low density lipoprotein in atherogenesis
Br Heart J
(1993)- et al.
Initiation of atherosclerotic lesions in cholesterol-fed rabbits II: selective retention of LDL vs selective increases in LDL permeability in susceptible sites of arteries
Arteriosclerosis
(1989) - et al.
Intact human ceruloplasmin oxidatively modifies low density lipoprotein
J Clin Invest
(1994)
There are more references available in the full text version of this article.
Cited by (1274)
Long-term polystyrene nanoplastic exposure disrupt hepatic lipid metabolism and cause atherosclerosis in ApoE<sup>-/-</sup> mice
2024, Journal of Hazardous MaterialsCholesterol crystals and atherosclerotic plaque instability: Therapeutic potential of Eicosapentaenoic acid
2022, Pharmacology and TherapeuticsA biological rationale for the disparate effects of omega-3 fatty acids on cardiovascular disease outcomes
2022, Prostaglandins Leukotrienes and Essential Fatty AcidsEicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitro
2020, Biochimica et Biophysica Acta - BiomembranesCitation Excerpt :We wanted to explore mechanisms that might contribute to such observed clinical results and that might be distinct to EPA. Oxidative modification of LDL and cellular membranes is causally related to atherosclerosis by contributing to a variety of processes, including endothelial dysfunction and vascular inflammation [18–20]. Membrane oxidative stress and dyslipidemia promote the formation of free radicals and cholesterol crystalline membrane domains associated with atherosclerosis [21–24].
Copyright © 1994 Published by Elsevier Ltd.